Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
Clinical trial NCT00052572 · COMPLETED
Trial details
- NCT number
- NCT00052572
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.